Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


22.10.2018

2 Am J Hematol
1 Ann Hematol
1 BMC Cancer
2 Cancer
1 Cancer Chemother Pharmacol
1 Eur J Haematol
1 Eur J Immunol
1 Exp Hematol
5 Leuk Lymphoma
5 Leukemia
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. ESTEY EH
    Acute myeloid leukemia: 2019 update on risk-stratification and management.
    Am J Hematol. 2018;93:1267-1291.
    PubMed     Text format     Abstract available

  2. SHORT NJ, Jabbour E, Naqvi K, Patel A, et al
    A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents.
    Am J Hematol. 2018 Oct 17. doi: 10.1002/ajh.25318.
    PubMed     Text format     Abstract available


    Ann Hematol

  3. LEE AC, Leo SW
    Juvenile myelomonocytic leukemia: a surprising cause of peri-orbital tumor and squint.
    Ann Hematol. 2018 Oct 12. pii: 10.1007/s00277-018-3510.
    PubMed     Text format    


    BMC Cancer

  4. LOPEZ-NIEVA P, Fernandez-Navarro P, Vaquero-Lorenzo C, Villa-Morales M, et al
    RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.
    BMC Cancer. 2018;18:430.
    PubMed     Text format     Abstract available


    Cancer

  5. MINA R, Joseph NS, Kaufman JL, Gupta VA, et al
    Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
    Cancer. 2018 Oct 17. doi: 10.1002/cncr.31718.
    PubMed     Text format     Abstract available

  6. HIDALGO-LOMICRONPEZ JE, Kanagal-Shamanna R, Quesada AE, Gong Z, et al
    Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.
    Cancer. 2018 Oct 15. doi: 10.1002/cncr.31663.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  7. NERSTING J, Nielsen SN, Grell K, Paerregaard M, et al
    Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy.
    Cancer Chemother Pharmacol. 2018 Oct 15. pii: 10.1007/s00280-018-3704.
    PubMed     Text format     Abstract available


    Eur J Haematol

  8. BERTOLI S, Paubelle E, Berard E, Saland E, et al
    Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels and their functional as well as prognostic roles in acute myeloid leukemia.
    Eur J Haematol. 2018 Oct 16. doi: 10.1111/ejh.13183.
    PubMed     Text format     Abstract available


    Eur J Immunol

  9. URI A, Luhder F, Kerkau T, Beyersdorf N, et al
    During acute Graft versus Host Disease CD28 deletion in donor CD8(+) , but not CD4(+) , T cells maintains anti-leukemia responses in mice.
    Eur J Immunol. 2018 Oct 15. doi: 10.1002/eji.201847669.
    PubMed     Text format     Abstract available


    Exp Hematol

  10. CHEN Y, Jones KL, Anastassiadis K, Kranz A, et al
    Distinct Pathways Affected by Menin versus MLL1/MLL2 in MLL-rearranged Acute Myeloid Leukemia.
    Exp Hematol. 2018 Oct 10. pii: S0301-472X(18)30851.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  11. DAVIDS MS, Kim HT, Yu L, De Maeyer G, et al
    Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia.
    Leuk Lymphoma. 2018 Oct 15:1-4. doi: 10.1080/10428194.2018.1519814.
    PubMed     Text format     Abstract available

  12. SOBAS M, Montesinos P, Boluda B, Bernal T, et al
    An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens.
    Leuk Lymphoma. 2018 Oct 15:1-6. doi: 10.1080/10428194.2018.1516875.
    PubMed     Text format     Abstract available

  13. BHANGOO MS, Saven A
    Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia.
    Leuk Lymphoma. 2018 Oct 15:1-3. doi: 10.1080/10428194.2018.1519809.
    PubMed     Text format    

  14. CHEN J, Ngo D, Aldoss I, Shayani S, et al
    Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2018 Oct 15:1-6. doi: 10.1080/10428194.2018.1519811.
    PubMed     Text format     Abstract available

  15. ZHANG S, Zhou W, Li Y, Yu S, et al
    Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO.
    Leuk Lymphoma. 2018 Oct 17:1-4. doi: 10.1080/10428194.2018.1520991.
    PubMed     Text format    


    Leukemia

  16. KRAFT B, Lombard J, Kirsch M, Wuchter P, et al
    SMC3 protein levels impact on karyotype and outcome in acute myeloid leukemia.
    Leukemia. 2018 Oct 15. pii: 10.1038/s41375-018-0287.
    PubMed     Text format    

  17. FRASER G, Cramer P, Demirkan F, Silva RS, et al
    Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Leukemia. 2018 Oct 12. pii: 10.1038/s41375-018-0276.
    PubMed     Text format     Abstract available

  18. OTHUS M, Sekeres MA, Nand S, Garcia-Manero G, et al
    Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studies.
    Leukemia. 2018 Oct 12. pii: 10.1038/s41375-018-0275.
    PubMed     Text format     Abstract available

  19. OTHUS M, Estey EH, Garcia-Manero G, Wood BL, et al
    Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.
    Leukemia. 2018 Oct 12. pii: 10.1038/s41375-018-0274.
    PubMed     Text format    

  20. ROSS DM, Pagani IS, Shanmuganathan N, Kok CH, et al
    Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.
    Leukemia. 2018 Oct 12. pii: 10.1038/s41375-018-0264.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  21. FEI DL, Zhen T, Durham B, Ferrarone J, et al
    Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1.
    Proc Natl Acad Sci U S A. 2018 Oct 15. pii: 1812669115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: